BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 7485745)

  • 1. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence patterns with concurrent platinum-based chemotherapy and accelerated hyperfractionated radiotherapy in stage III and IV head and neck cancer patients.
    Koness RJ; Glicksman A; Liu L; Coachman N; Landman C; Slotman G; Wanebo HJ
    Am J Surg; 1997 Nov; 174(5):532-5. PubMed ID: 9374231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer.
    Glicksman AS; Wanebo HJ; Slotman G; Liu L; Landmann C; Clark J; Zhu TC; Lohri A; Probst R
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):721-9. PubMed ID: 9336155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin-C in head and neck carcinoma. A pilot study.
    Abitbol AA; Schwade JG; Lewin AA; Sridhar K; Brandon AH; Markoe AM; Casiano RR; Houdek PV; Serago C; Miller DJ
    Am J Clin Oncol; 1992 Jun; 15(3):250-5. PubMed ID: 1590280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV).
    Wanebo HJ; Chougule P; Ready N; Koness RJ; Akerley W; McRae R; Nigri P; Leone L; Webber B; Safran H
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):77-84. PubMed ID: 10210544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer.
    Wanebo HJ; Chougule P; Akerley WL; Koness RJ; McRae R; Nigri P; Leone L; Ready N; Safran H; Webber B; Cole B
    Am J Surg; 1997 Nov; 174(5):518-22. PubMed ID: 9374228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
    Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer.
    Lavertu P; Adelstein DJ; Saxton JP; Secic M; Wanamaker JR; Eliachar I; Wood BG; Strome M
    Head Neck; 1997 Oct; 19(7):559-66. PubMed ID: 9323143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
    Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
    Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H
    Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer.
    Puc MM; Chrzanowski FA; Tran HS; Liu L; Glicksman AS; Landman C; Slotman GJ
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):337-42. PubMed ID: 10722006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy.
    Adelstein DJ; Saxton JP; Lavertu P; Rybicki LA; Esclamado RM; Wood BG; Strome M; Carroll MA
    J Clin Oncol; 2002 Mar; 20(5):1405-10. PubMed ID: 11870186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer.
    Glicksman AS; Slotman G; Doolittle C; Clark J; Koness J; Coachman N; Posner M; DeRosa E; Wanebo H
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1043-50. PubMed ID: 7961010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.